Latest Healthcare News

Barramundi Limited’s portfolio delivered a 2.2% gross return in July, outpacing the S&P/ASX200 hedged benchmark, driven by strong performances in healthcare and financials alongside strategic portfolio adjustments.

Sigma Healthcare will release its FY26 full year results on 27 August, unveiling a new segment reporting structure dividing Australia and International operations. The update aims to clarify performance amid ongoing international growth and merger integration.

L1 Group has partnered with Dr Andrew Lin to launch PXC Advisors, a global long short investment manager boasting a 51% annualised return since 2024. The strategy will open to external investors in September 2026 and take over management of the Platinum International Technology Fund.

ResMed Inc. posted a 10% rise in fiscal 2026 revenue to $5.65 billion, bolstered by the acquisition of Noctrix Health and an agreement to sell its MatrixCare business. The company continues to invest in AI-powered digital health solutions amid ongoing patent litigation and a shifting regulatory landscape.

Green Cross Health CEO Rachael Newfield will step down in January 2027 following the sale of the Medical division, paving the way for a new pharmacy-centric leadership role.

Austco Healthcare has completed the $2.24 million acquisition of Medical Communications Systems, transitioning its long-term South Australian reseller into a direct sales operation to deepen market engagement.

Proteomics International has achieved a key patent acceptance in Australia for its PromarkerEndo blood test, reinforcing its intellectual property portfolio and commercialisation strategy in a major healthcare market.

Charter Hall Long WALE REIT reported a 128% surge in statutory profit to $275.9 million for FY26, supported by a $150.7 million property revaluation gain and a $248 million net acquisition spree. The REIT also completed a $2 billion debt refinancing, extending maturities and cutting margins.

Bailador Technology Investments (ASX:BTI) posted a 64% drop in net profit to $6.9 million for FY26, amid a 55% fall in gains on financial assets. Despite this, the fund declared a fully franked 3.5 cent dividend and highlighted strong AI adoption and growth across its private tech portfolio.

Vital Healthcare Property Trust (NZX:VHP) delivered a robust FY26, marked by a successful management internalisation, 23.5% AFFO growth, and a stable distribution payout, underpinning its position as a leading healthcare infrastructure owner in Australasia.

Pro Medicus’ US subsidiary Visage Imaging has landed a 7-year, A$23 million contract to deploy its cloud-based Visage 7 platform across St. Luke’s Health System, marking a further expansion in North America.

Anteris Technologies posted a $51.7 million loss in H1 2026 amid ramped-up R&D and clinical trial activity, supported by a $320 million capital raise and Medicare reimbursement for its DurAVR heart valve trial.